molecular
diagnost
method
evolv
matur
consider
last
sever
decad
constantli
evalu
adopt
clinic
laboratori
identif
infecti
pathogen
advanc
technolog
fluoresc
electron
instrument
autom
sensor
made
overal
diagnost
process
accur
sensit
rapid
nucleic
acid
base
detect
procedur
reli
fundament
principl
dna
replic
emerg
popular
standard
diagnost
method
sever
commerci
assay
current
avail
base
differ
nucleic
acid
amplif
techniqu
review
focus
major
amplif
chemistri
use
develop
commerci
assay
discuss
applic
clinic
virolog
laboratori
develop
pcr
kari
mulli
revolution
detect
microbi
pathogen
clinic
specimen
pcr
highli
sensit
method
involv
cyclic
heat
cool
reaction
mixtur
facilit
amplif
target
dna
method
consist
three
basic
step
denatur
anneal
extens
reaction
mixtur
requir
four
primari
compon
templat
dna
primer
nucleotid
dna
polymeras
fig
doublestrand
target
dna
dsdna
thermal
denatur
form
singlestrand
dna
templat
ssdna
oligonucleotid
primer
anneal
complementari
target
sequenc
nucleic
acid
templat
extend
dna
polymeras
thu
creat
result
pcr
product
amplicon
reaction
occur
programm
thermal
http
doi
clinic
microbiologist
constantli
strive
deliv
accur
test
result
quickli
ensur
appropri
treatment
infect
control
measur
implement
time
convent
diagnost
method
microscopi
cultur
labori
timeconsum
requir
consider
technic
skill
accur
analysi
pathogen
technolog
revolut
occur
last
decad
consider
improv
expand
diagnost
capabl
modern
clinic
microbiolog
laboratori
particular
develop
nucleic
acid
amplif
chemistri
allow
rapid
amplif
character
target
nucleic
acid
aid
develop
numer
commerci
assay
sever
relev
viral
pathogen
tabl
amplif
chemistri
often
modifi
detect
multipl
target
improv
overal
sensit
specif
method
control
specif
reaction
condit
addit
special
design
oligonucleotid
enzym
diagnost
method
autom
convert
sampletoansw
format
manipul
smaller
volum
sampl
deliv
accur
quantifi
test
result
short
amount
time
furthermor
autom
elimin
need
extens
train
laboratori
personnel
reduc
possibl
contamin
human
error
review
focus
major
amplif
chemistri
includ
target
amplif
signal
amplif
probe
amplif
current
use
develop
commerci
assay
detect
viral
pathogen
discuss
advantag
disadvantag
techniqu
applic
clinic
virolog
laboratori
target
amplif
popular
method
dna
rna
analysi
wide
implement
detect
viral
pathogen
method
nucleic
acid
interest
enzymat
amplifi
amplifi
product
detect
variou
method
electrophoresi
electrochemiluminesc
label
oligonucleotid
hybrid
complementari
target
sequenc
target
amplif
techniqu
includ
sever
chemistri
polymeras
chain
reaction
pcr
nucleic
acid
sequencebas
amplif
nasba
transcript
mediat
amplif
tma
loopmedi
isotherm
amplif
lamp
strand
displac
amplif
sda
describ
detail
aptima
hpv
cycler
step
repeat
sever
cycl
n
produc
multipl
copi
n
target
sequenc
end
product
form
detect
variou
method
agaros
gel
electrophoresi
colorimetr
detect
chemiluminesc
gel
electrophoresi
use
fluoresc
dye
ethidium
bromid
sybr
green
sybr
gold
sybr
safe
intercal
stack
dna
base
fluoresc
uv
exposur
colorimetr
detect
label
oligonucleotid
incorpor
within
target
dna
complex
form
detect
use
chromogen
substrat
chemiluminesc
detect
enzym
catalyz
chemic
reaction
involv
amplifi
nucleic
acid
emit
energi
form
light
visual
autoradiographi
ccd
imag
altern
realtim
pcr
also
known
quantit
pcr
qpcr
amplif
detect
occur
simultan
elimin
pcr
postprocess
step
may
reduc
overal
turnaround
time
depend
assay
design
accumul
amplif
product
measur
real
time
reaction
progress
thu
quantifi
cycl
although
realtim
pcr
use
qualit
quantit
dna
analysi
method
employ
dsdna
intercal
dye
sybr
green
evagreen
fluorophorelabel
oligonucleotid
scorpion
amplifluor
taqman
etc
detect
quantif
amplifi
product
fluorescentlabel
oligonucleotid
subdivid
three
categori
base
type
fluoresc
molecul
usedprim
probe
scorpion
amplifluor
etc
hydrolysi
probe
taqman
etc
hybrid
probe
fret
molecular
beacon
etc
dsdna
intercal
dye
increas
fluoresc
bind
minor
groov
dna
fluorophorelabel
oligonucleotid
either
hybrid
pcr
product
undergo
hydrolysi
separ
fluorophor
quench
dye
result
increas
signal
fig
quench
chemistri
multicod
rtx
use
synthet
dna
basepair
ic
ig
isobas
sitespecif
incorpor
quencher
molecul
quench
fluoresc
measur
amplif
realtim
commerci
realtim
pcr
assay
develop
detect
quantif
relev
virus
epsteinbarr
viru
ebv
hepat
c
viru
hcv
hepat
b
viru
hbv
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
convent
pcr
modifi
time
increas
sensit
specif
nestedpcr
detect
rna
target
reversetranscript
rtpcr
amplifi
multipl
target
reaction
mixtur
multiplex
pcr
nest
pcr
use
two
set
amplif
primer
two
success
pcr
reaction
first
stage
pcr
first
set
primer
bind
dna
templat
either
side
target
sequenc
sequenc
flank
end
target
fig
amplifi
product
gener
use
templat
second
stage
reaction
second
set
primer
anneal
sequenc
intern
first
set
sensit
specif
increas
method
first
amplicon
provid
templat
second
reaction
second
primer
set
anneal
first
amplicon
complementari
sequenc
amplifi
product
detect
way
convent
pcr
disadvantag
nest
pcr
long
turnaround
time
due
timeconsum
postpcr
step
difficulti
autom
procedur
reaction
perform
singl
tube
requir
tube
transfer
increas
risk
amplicon
contamin
high
amplicon
yield
particularli
process
employ
separ
tube
stage
commerci
nest
pcr
multiplex
nest
pcr
assay
larg
overcom
limit
develop
molecular
diagnosi
respiratori
virus
flu
b
coronaviru
enteroviru
respiratori
syncyti
viru
rsv
parainfluenza
rhinoviru
adenoviru
bocaviru
human
metapneumoviru
hmpv
virus
caus
mening
enceph
cytomegaloviru
cmv
enteroviru
hsv
human
herpesviru
type
human
parechoviru
varicella
zoster
viru
vzv
gastrointestin
virus
adenoviru
f
astroviru
noroviru
gigii
rotaviru
sapoviru
assay
demonstr
sensit
specif
viral
target
variou
clinic
trial
studi
pcr
also
amplifi
rna
target
preced
revers
transcript
rt
reaction
rtpcr
target
rna
templat
convert
complementari
dna
cdna
sequenc
revers
transcriptas
fig
newli
synthes
cdna
amplifi
convent
pcr
commerci
rtpcr
kit
avail
detect
hcv
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
dengu
viru
viru
pcr
amplif
also
multiplex
detect
sever
target
singl
reaction
benefici
infect
control
time
treatment
decis
substanti
less
expens
detect
individu
pathogen
monoplex
realtim
pcr
multiplex
pcr
multipl
primer
pair
complementari
specif
target
interest
use
simultan
amplifi
correspond
dna
fragment
singl
multiplex
reaction
multipl
parallel
singleplex
reaction
develop
sensit
specif
multiplex
pcr
panel
care
taken
design
ensur
compat
primer
pcr
condit
commerci
multiplex
syndrom
panel
avail
detect
respiratori
gastrointestin
virus
necess
stringent
temperatur
control
make
pcr
expens
timeconsum
process
would
difficult
implement
low
resourc
field
set
unlik
pcr
isotherm
amplif
method
carri
constant
temperatur
elimin
need
sophist
expens
thermal
cycler
isotherm
method
rapid
sensit
requir
less
energi
pcr
easier
implement
pointofcar
low
resourc
set
addit
risk
contamin
reduc
method
usual
perform
enclos
microsystem
portabl
devic
primari
challeng
isotherm
amplif
includ
design
compat
primer
pair
requir
specif
assay
optim
potenti
gener
nonspecif
amplifi
product
nasba
sensit
isotherm
amplif
system
primarili
use
identif
rna
target
three
enzym
use
reactionavian
myeloblastosi
viru
revers
transcriptas
rnase
h
rna
polymeras
ultim
produc
ssrna
termin
amplif
product
sequencespecif
primer
bind
target
sequenc
amplifi
revers
transcriptas
extend
produc
rnadna
hybrid
rnase
h
degrad
rna
portion
hybrid
second
primer
bind
remain
cdna
fig
second
primer
extens
gener
complementari
strand
form
dsdna
molecul
primer
includ
rna
polymeras
promot
site
multipl
rna
copi
transcrib
dna
templat
ssrna
end
product
detect
variou
method
gel
electrophoresi
enzymelink
gel
assay
enzymat
bead
base
detect
electrochemiluminesc
primari
concern
nasba
rna
integr
control
reaction
temperatur
enzym
involv
thermolabil
commerci
nasba
assay
clinic
use
detect
rsv
cmv
human
papillomaviru
hpv
multiplex
nasba
assay
hcv
develop
demonstr
analyt
sensit
copiesml
clinic
sensit
specif
chemiluminesc
signal
probeamplicon
hybrid
measur
perform
tma
critic
depend
primer
design
like
nasba
precis
control
reaction
temperatur
import
denatur
secondari
structur
commerci
tma
assay
avail
detect
quantif
hcv
hbv
demonstr
equival
perform
compar
commerci
realtim
pcr
assay
sda
isotherm
amplif
reaction
dna
rna
target
perform
three
simpl
stepsa
heat
denatur
target
dna
presenc
primer
reagent
b
addit
hincii
restrict
endonucleas
exo
minu
klenow
fragment
c
incub
sampl
first
stage
reaction
target
dna
sequenc
duplic
use
four
primer
presenc
dna
polymeras
result
addit
restrict
endonucleas
site
end
amplifi
target
fig
second
stage
multipl
cycl
involv
nick
restrict
endonucleas
site
extend
nick
dna
polymeras
strand
displac
occur
result
exponenti
amplif
target
amplifi
target
detect
photometri
sequencespecif
label
probe
chemiluminesc
limit
sda
includ
ineffici
amplifi
long
target
sequenc
probabl
produc
consider
background
reaction
due
unspecif
primer
bind
commerci
sda
assay
develop
detect
hsv
demonstr
sensit
specif
respect
lamp
isotherm
amplif
use
set
differ
primer
individu
recogn
distinct
sequenc
target
dna
four
core
primer
employ
lamp
system
fip
forward
inner
primer
bip
backward
inner
primer
forward
primer
backward
primer
lamp
reaction
start
fip
bind
region
target
dna
initi
complementari
strand
synthesi
fig
follow
strand
synthesi
primer
hybrid
target
dna
extend
dna
polymeras
primer
extens
displac
fiplink
complementari
strand
form
selfhybrid
loop
structur
end
strand
serv
templat
bip
initi
complementari
strand
synthesi
open
end
loop
complementari
strand
synthes
hybrid
extens
displac
reaction
repeat
primer
gener
doubl
loop
dumbbellshap
dna
nucleotid
ad
open
end
dumbbellshap
dna
convert
stemloop
structur
stemloop
dna
structur
serv
initi
second
stage
ie
exponenti
lamp
cycl
stage
fip
hybrid
loop
initi
strand
synthesi
therebi
displac
strand
form
new
loop
end
nucleotid
addit
step
repeat
follow
dna
extens
displac
fip
strand
form
dumbbellshap
dna
subsequ
selfprim
strand
displac
dna
synthesi
yield
one
complementari
structur
origin
stemloop
dna
one
gap
repair
stemloop
dna
product
use
templat
bip
anneal
displac
cycl
repeat
reaction
proce
product
grow
form
long
concatam
amplifi
product
detect
indirect
detect
method
like
turbid
nonspecif
dye
compar
convent
pcr
lamp
assay
highli
sensit
rapid
costeffect
easili
implement
resourcelimit
set
howev
complic
primer
design
possibl
carryov
contamin
still
remain
concern
lampbas
assay
commerci
lamp
assay
demonstr
sensit
specif
avail
detect
hsv
lampbas
assay
also
develop
detect
emerg
viral
pathogen
sarscov
chikungunya
dengu
viru
revers
transcriptas
lamp
rtlamp
assay
develop
detect
sever
virus
footandmouth
diseas
viru
zika
viru
influenza
viru
cmv
hpv
bk
vzv
hsv
virus
near
isotherm
amplif
method
reli
rapid
identif
small
dna
rna
fragment
directli
gener
target
nucleic
acid
method
set
targetspecif
primer
nick
endonucleas
strand
displac
dna
polymeras
use
isotherm
unwind
subsequ
gener
amplif
small
fragment
fig
insert
nick
enzym
recognit
site
insid
target
sequenc
facilit
amplif
procedur
dna
polymeras
initi
primer
extens
nick
creat
nick
enzym
releas
small
oligonucleotid
fragment
repeat
nick
polymer
strand
displac
result
linear
amplif
small
oligonucleotid
amplicon
gener
detect
use
varieti
probe
format
molecular
beacon
later
flow
sandwich
primari
limit
near
reaction
includ
gener
larg
number
nonspecif
product
inhibit
progress
forward
reaction
also
limit
detect
sensit
thu
may
requir
specif
accur
amplif
analysi
method
avoid
detect
error
commerci
pointofcar
poc
near
assay
avail
flu
ab
rsv
provid
result
within
minut
demonstr
sensit
specif
flu
ab
compar
viral
cultur
howev
compar
multiplex
realtim
rtpcr
assay
poc
near
assay
demonstr
sensit
flu
sensit
flu
b
poorer
sensit
attribut
low
posit
sampl
limit
detect
hda
isotherm
process
dna
amplif
reli
complementari
strand
displac
abil
thermost
dna
helicas
use
free
energi
atp
hydrolysi
helicas
presenc
accessori
protein
mutl
catalyz
unwind
dsdna
fig
unwound
ssdna
strand
coat
ssdnabind
protein
sequencespecif
primer
hybrid
ssdna
templat
dna
polymeras
extend
anneal
primer
convert
ssdna
dsdna
act
substrat
helicas
thu
initi
subsequ
round
exponenti
amplif
target
sequenc
although
helicas
unwind
dsdna
singl
temperatur
observ
initi
heatinduc
denatur
anneal
step
increas
amplif
effici
yield
sensit
speed
robust
hda
assay
improv
restrict
endonucleasemedi
dna
helicas
home
macromolecular
crowd
agent
optim
reaction
enzym
mix
hda
assay
critic
depend
primer
design
often
vulner
primerdim
amplicon
contamin
amplif
primerdim
place
target
nucleic
acid
lead
erron
detect
remain
one
major
concern
hda
base
assay
current
hdabas
commerci
avail
assay
develop
detect
hsv
flu
b
rsv
hmpv
hsv
hda
assay
demonstr
posit
percent
agreement
ppa
neg
percent
agreement
npa
compar
shell
vial
viru
cultur
immunofluoresc
type
like
isotherm
reaction
hda
assay
rapid
sensit
inexpens
perform
without
sophist
instrument
success
implement
low
resourc
set
rca
isotherm
process
use
dna
rna
polymeras
gener
ssdna
rna
strand
util
principl
roll
circl
replic
initi
primer
anneal
replic
origin
site
circular
templat
polymeras
facilit
continu
addit
nucleotid
lead
strand
result
long
ssdna
rna
tandem
repeat
fig
depend
number
anneal
primer
rca
classifi
linear
rca
produc
copi
exponenti
rca
produc
copi
linear
rca
singl
complementari
primer
gener
singl
amplifi
product
link
initi
primer
exponenti
rca
use
two
primer
second
primer
bind
ssdna
product
first
primer
initi
amplif
circul
oligonucleotid
probe
padlock
probe
plp
enhanc
specif
multiplex
abil
rca
end
probe
design
recogn
adjac
sequenc
target
strand
properli
hybrid
end
join
use
ligas
result
circular
probe
follow
circular
probe
replic
rca
product
label
detect
use
variou
signal
readout
techniqu
gel
electrophoresi
fluoresc
spectroscopi
microscopi
high
specif
ensur
sinc
hybrid
circular
occur
target
sequenc
correctli
recogn
end
probe
rcabas
assay
develop
fulllength
genom
amplif
hbv
sampl
viral
load
low
copi
reaction
commerci
rca
kit
aid
prepar
circular
dna
templat
cycl
sequenc
clone
transform
use
detect
plant
virus
howev
current
commerci
rca
assay
avail
detect
viral
pathogen
affect
human
sever
challeng
limit
applic
rca
commerci
diagnost
purpos
includ
technic
concern
prepar
larg
quantiti
high
puriti
circular
templat
enzym
effici
small
dna
substrat
extens
optim
requir
rca
product
length
sequenc
composit
signal
amplif
altern
enzymat
amplif
amplifi
detect
signal
gener
extern
probe
molecul
bind
target
nucleic
acid
signal
produc
directli
proport
amount
target
present
reaction
mix
therefor
method
also
suitabl
develop
quantit
assay
sensit
specif
determin
design
probe
molecul
recogn
target
sequenc
bdna
technolog
power
tool
reliabl
quantif
target
nucleic
acid
primarili
use
monitor
patient
antivir
therapi
hiv
hcv
hbv
unlik
pcr
reli
vitro
amplif
target
sequenc
bdna
base
seri
specif
hybrid
reaction
chemiluminesc
detect
hybrid
probe
assay
use
multipl
synthet
captur
oligonucleotid
label
extend
captur
extend
hybrid
complementari
region
target
nucleic
acid
form
sandwich
complex
probe
target
sequenc
fig
captur
extend
bind
effici
target
nucleic
acid
sequenc
well
captur
probe
attach
immobil
surfac
microtit
plate
captur
extend
hybrid
captur
probe
sampl
contain
viral
nucleic
acid
ad
hybrid
follow
hybrid
label
extend
ad
mix
bind
contigu
region
target
also
preamplifi
oligonucleotid
hybrid
label
extend
preamplifi
molecul
initi
signal
amplif
process
preamplifi
molecul
also
harbor
region
hybrid
multipl
bdna
amplifi
molecul
form
branch
structur
branch
structur
final
bound
alkalin
phosphatas
ap
label
oligonucleotid
complementari
bdna
amplifi
sequenc
chemiluminesc
product
ap
reaction
gener
bdna
signal
directli
proport
amount
dna
rna
target
present
origin
sampl
complex
method
addit
intellectu
properti
surround
bdna
technolog
limit
applic
develop
molecular
infecti
diseas
assay
current
two
us
fda
approv
commerci
bdna
assay
avail
versant
rna
assay
hiv
versant
hcv
assay
hcv
dynam
rang
hiv
hcv
assay
copiesml
iuml
respect
howev
compar
commerci
realtim
pcr
assay
bdnabas
hbv
assay
demonstr
lower
sensit
less
linear
dynam
rang
bdna
vs
realtim
pcr
therebi
indic
assay
might
insuffici
detect
low
level
viral
load
last
decad
bdna
technolog
use
develop
modifi
fluoresc
situ
hybrid
fish
assay
detect
hbv
oncogen
fusion
gene
bdna
also
adapt
luminex
xmap
bead
array
technolog
direct
quantif
dna
rna
protein
target
hybrid
captur
technolog
reli
captur
detect
rna
dna
hybrid
complex
method
target
dna
hybrid
synthet
complementari
rna
probe
gener
rnadna
hybrid
fig
rnadna
hybrid
captur
onto
solid
phase
coat
univers
captur
antibodi
specif
rnadna
hybrid
antibodyhybrid
conjug
detect
antirnadna
monoclon
antibodi
conjug
sever
ap
molecul
multipl
detect
antibodi
bind
rnadna
hybrid
result
signal
amplif
amplifi
signal
detect
use
chemiluminesc
substrat
measur
luminomet
current
commerci
hybrid
captur
assay
avail
detect
hpv
hybrid
captur
assay
first
commerci
avail
assay
diagnosi
hpv
sinc
updat
version
hpv
hybrid
captur
assay
releas
demonstr
compar
perform
molecular
diagnost
method
consid
reliabl
robust
assay
cervic
cancer
screen
howev
hpv
assay
rel
lower
analyt
sensit
copi
hpv
dna
compar
pcr
hpv
screen
clinic
sensit
specif
import
analyt
perform
predict
highrisk
case
cervic
cancer
posit
result
may
clinic
irrelev
primari
limit
assay
inabl
distinguish
differ
strain
hpv
essenti
effici
risk
analysi
determin
persist
infect
howev
futur
hybrid
captur
assay
seem
question
manufactur
appear
focus
tradit
target
amplif
methodolog
well
newer
technolog
probe
amplif
techniqu
reli
hybrid
amplif
synthet
oligonucleotid
probe
complementari
target
nucleic
acid
reaction
gener
multipl
copi
bound
probe
detect
variou
method
gel
electrophoresi
fluoresc
label
detect
method
consist
four
major
stepssampl
prepar
denatur
target
dna
hybrid
label
probe
remov
unbound
probe
detect
hybrid
probe
lcr
chemistri
use
four
synthet
oligonucleotid
nucleotid
length
two
adjac
oligonucleotid
primer
uniqu
hybrid
one
strand
target
dna
complementari
set
adjac
oligonucleotid
bind
strand
target
dna
fig
nickclos
reaction
thermost
dna
ligas
join
two
adjac
oligonucleotid
set
nucleotid
perfectli
basepair
oligonucleotid
junction
hybrid
complementari
sequenc
orient
strand
target
dna
ligat
product
serv
templat
subsequ
reaction
cycl
lead
exponenti
amplif
similar
pcr
lcr
product
gener
differenti
detect
sever
method
polyacrylamid
gel
electrophoresi
fluoresc
label
detect
autoradiographi
lcr
assay
sensit
specif
easi
perform
readili
autom
unlik
pcr
new
dna
synthes
therefor
misincorpor
nucleotid
sequenc
present
target
dna
replic
final
product
potenti
drawback
lcr
includ
increas
background
signal
fals
posit
result
target
independ
ligat
occur
absenc
templat
dna
difficulti
inactiv
postamplif
product
inabl
incorpor
effect
contamin
control
method
lcr
assay
success
develop
detect
sever
virus
hpv
hsv
hbv
howev
commerci
lcrbase
viral
assay
current
avail
us
gaplcr
glcr
modifi
lcr
reduc
background
gener
targetindepend
bluntend
ligat
reaction
gap
anneal
probe
fill
dna
polymeras
subsequ
join
dna
ligas
modifi
gap
ligas
chain
reaction
glcr
develop
detect
hcv
detect
fewer
copi
synthet
rna
transcript
demonstr
compar
result
nest
rnapcr
detect
cpt
isotherm
amplif
method
detect
quantifi
low
amount
target
dna
without
amplif
target
dna
sequenc
sequencespecif
chimer
probe
base
length
typic
dnarnadna
anneal
complementari
singl
strand
target
dna
act
substrat
thermost
rnase
h
fig
rnase
h
specif
degrad
rna
portion
chimer
probe
disassoci
shorter
dna
probe
fragment
target
dna
make
avail
hybrid
next
probe
molecul
accumul
probe
fragment
detect
use
fluoresc
marker
gel
electrophoresi
amplifi
secondari
amplif
system
commerci
kit
combin
quantit
realtim
pcr
cptbase
detect
use
rapid
detect
quantif
also
discrimin
cpt
also
employ
differenti
strain
vzv
rapid
specif
detect
resist
influenza
virus
hcv
cleavaseinvad
technolog
isotherm
probe
amplif
method
detect
dna
rna
target
high
sensit
specif
assay
use
two
oligonucleotid
probesth
invad
oligonucleotid
allelespecif
primari
oligonucleotid
two
probe
hybrid
singlestrand
target
form
uniqu
partial
overlap
threedimension
invad
flap
structur
fig
threedimension
structur
recogn
cleavas
flap
endonucleas
fen
cleav
flap
primari
probe
cleav
flap
product
subsequ
anneal
fluoresc
reson
energi
transfer
fret
probe
initi
second
invas
cleavag
reaction
releas
fluoresc
dye
detect
fluoromet
measur
fluoresc
signal
gener
primari
probe
match
target
sequenceth
cleavas
remain
inact
mismatch
commerci
invad
assay
develop
rapid
differenti
hcv
genotyp
compat
variou
commerci
avail
pcrbase
hcv
noncod
region
amplif
assay
invad
assay
also
develop
classif
hbv
commerci
invad
assay
improv
specif
avail
detect
hpv
modifi
invad
assay
combin
pcr
invad
chemistri
singl
closedtub
continuousreact
format
develop
simultan
differenti
hsv
clinic
sensit
specif
addit
invad
assay
also
adapt
detect
novel
virus
african
swine
fever
viru
demonstr
dynam
rang
copi
invad
assay
also
develop
snp
genotyp
two
major
limit
first
assay
requir
either
larg
amount
sampl
dna
initi
amplif
sampl
dna
second
current
format
assay
demonstr
poor
multiplex
abil
genotyp
one
snp
per
reaction
rapid
accur
diagnosi
infecti
pathogen
proven
paramount
improv
overal
clinic
outcom
patient
infect
control
last
two
decad
molecular
test
method
consider
improv
diagnosi
viral
pathogen
often
consid
new
gold
standard
method
implement
routin
clinic
virolog
laboratori
still
use
refer
test
commerci
assay
base
fundament
nucleic
acid
amplif
extens
develop
detect
identif
quantif
relev
viral
pathogen
assay
requir
minim
handson
time
short
turnaround
time
autom
provid
result
directli
specimen
thu
elimin
lengthi
preand
postprocess
step
primari
advantag
molecular
assay
high
sensit
specif
compar
convent
diagnost
method
howev
higher
rate
pathogen
detect
test
perform
result
analyz
base
clinic
sign
symptom
initi
specif
treatment
primari
concern
molecular
assay
complex
level
technic
expertis
requir
potenti
high
cost
per
test
howev
mani
chemistri
evolv
moder
low
complex
sampletoansw
system
even
achiev
cliawaiv
pointofcar
poc
statu
although
diagnost
compani
develop
strategi
help
reduc
cost
clinic
laboratori
evalu
patient
popul
size
capac
perform
costanalysi
specif
set
implement
specif
test
author
contribut
equal
phase
prepar
review
articl
dunbar
da
employe
luminex
corpor
none
applic
